Powder: -20°C for 3 years | In solvent: -80°C for 1 year
M-89, a highly potent and specific inhibitor of the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction, exhibits a Kd of 1.4 nM for menin binding. This compound holds potential for treating MLL leukemia.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 65,000 |
2 mg | 在庫あり | ¥ 91,000 |
5 mg | 在庫あり | ¥ 137,000 |
10 mg | 在庫あり | ¥ 195,500 |
25 mg | 在庫あり | ¥ 296,000 |
50 mg | 在庫あり | ¥ 397,000 |
100 mg | 在庫あり | ¥ 539,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 203,000 |
説明 | M-89, a highly potent and specific inhibitor of the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction, exhibits a Kd of 1.4 nM for menin binding. This compound holds potential for treating MLL leukemia. |
ターゲット&IC50 | Menin-MLL:1.4 nM (kd) |
分子量 | 657.87 |
分子式 | C37H47N5O4S |
CAS No. | 2363165-42-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7 mg/mL (10.64 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
M‑89 2363165-42-6 Chromatin/Epigenetic Histone Methyltransferase Epigenetic Reader Domain M?89 Inhibitor inhibit inhibitor